Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies

Exploratory Investigation on Functional Significance ofETS2andSIM2Genes in Down Syndrome

(2013) Arpita Chatterjee et al.   DISEASE MARKERS

Differential Allelic Distribution of V-ets Erythroblastosis Virus E26 Oncogene Homolog2 (ETS2) Functional Polymorphisms in Different Group of Patients

(2011) ARPITA CHATTERJEE et al.   GENE EXPRESSION

Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease

(2010) Serhan Zenger et al.   CLINICAL & EXPERIMENTAL METASTASIS

Genome-wide Linkage Scan Reveals Three Putative Breast-Cancer-Susceptibility Loci

(2009) Juan Manuel Rosa-Rosa et al.   AMERICAN JOURNAL OF HUMAN GENETICS

ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells

(2009) M. J. Stankiewicz et al.   BLOOD

Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma

(2009) Zhu-Qing Zhou et al.   BMC CANCER

Molecular genetic analysis of Down syndrome

(2009) David Patterson   HUMAN GENETICS

Hematopoietic defects in the Ts1Cje mouse model of Down syndrome

(2008) C. L. Carmichael et al.   BLOOD

Identification of dysregulated genes in lymphocytes from children with Down syndrome

(2008) Cesar A. Sommer et al.   GENOME

Acute Leukemias in Children with Down Syndrome

(2008) C. Michel Zwaan et al.   PEDIATRIC CLINICS OF NORTH AMERICA

FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease

(2008) Rong Chen et al.   GENOME BIOLOGY